Endogenous retroelements as alarms for disruptions to cellular homeostasis.


Journal

Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956

Informations de publication

Date de publication:
01 2023
Historique:
received: 17 06 2022
revised: 28 08 2022
accepted: 07 09 2022
pubmed: 11 10 2022
medline: 31 12 2022
entrez: 10 10 2022
Statut: ppublish

Résumé

Endogenous retroelements are DNA sequences which can duplicate and move to new locations in the genome. Actively moving endogenous retroelements can be disruptive to the host, and their expression is therefore often repressed. Interestingly, drugs that disrupt the repression of endogenous retroelements show promise for treating cancer. Expressed endogenous retroelements can activate innate immune receptors that activate the antiviral response, potentially leading to the death of cancer cells. We discuss disruptions to cellular processes which can lead to activation of the antiviral state from endogenous retroelements, and present the 'fire alarm hypothesis', where we argue that endogenous retroelements act as alarms for disruptions to these cellular processes. Furthermore, we discuss the properties of endogenous retroelements which make them suitable as alarms.

Identifiants

pubmed: 36216729
pii: S2405-8033(22)00191-1
doi: 10.1016/j.trecan.2022.09.001
pii:
doi:

Substances chimiques

Retroelements 0
Antiviral Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-68

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests D.D.D.C. reports grants from Princess Margaret Cancer Foundation, the Canadian Institutes of Health Research, and Canada Research Chair during the conduct of the study; grants from Pfizer and other support from Adela, Inc outside the submitted work. The other authors declare no conflicts of interest.

Auteurs

Håvard T Lindholm (HT)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Raymond Chen (R)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Daniel D De Carvalho (DD)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Electronic address: daniel.decarvalho@uhnresearch.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH